MedinCell S.A.

ENXTPA:MEDCL Stock Report

Market Cap: €491.1m

MedinCell Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MEDCL?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme1,340,7894.59%
VC/PE Firms1,526,2245.22%
Individual Insiders4,609,73415.8%
Institutions8,224,52928.1%
General Public13,527,98146.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 53.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.03%
Mirova Société Anonyme
2,055,476€34.5m17.9%0.83%
6.58%
Anh Nguyen
1,923,043€32.3m0%no data
5.22%
Crédit Mutuel Innovation
1,526,224€25.6m0%68.2%
5.2%
Sabine Nguyen
1,519,423€25.5m0%no data
4.59%
MedinCell S.A., ESOP
1,340,789€22.5m0%no data
3.99%
Franck Sturtz
1,167,268€19.6m0%no data
3.74%
Seventure Partners
1,094,030€18.4m0%45.22%
3.65%
BNP Paribas Développement SA, SCR
1,066,358€17.9m0%79.45%
3%
Amundi Asset Management SAS
877,600€14.7m0%no data
2.46%
Syquant Capital SAS
719,267€12.1m0%1.16%
2.14%
Polar Capital Holdings Plc
626,082€10.5m0%0.04%
0.94%
Saint Olive Gestion
275,000€4.6m0%0.48%
0.94%
BFT Investment Managers
273,393€4.6m0%0.65%
0.92%
Financiere Arbevel
267,676€4.5m0%0.93%
0.81%
Mandarine Gestion
235,300€4.0m0%0.2%
0.48%
SG 29 Haussmann SAS
140,000€2.4m0%0.03%
0.4%
LBP AM
117,908€2.0m0%0.01%
0.29%
Edmond de Rothschild Asset Management (France)
83,952€1.4m0%0.02%
0.28%
Sycomore Asset Management SA
82,227€1.4m0%0.04%
0.26%
MCA Finance
75,602€1.3m0%1.36%
0.21%
Hermitage Gestion Privée
60,000€1.0m0%4.09%
0.17%
Wellington Management Group LLP
50,088€841.5k0.17%no data
0.11%
Claresco Finance
33,000€554.4k0%0.21%
0.092%
UBS Asset Management AG
26,750€449.4k0%no data
0.056%
Financiere de La Cite SAS
16,375€275.1k0%0.61%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 07:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MedinCell S.A. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexandru CogutBryan Garnier & Co
Oscar Haffen LammBryan Garnier & Co
Raghuram SelvarajuH.C. Wainwright & Co.